Two Sigma Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,001
Closed -$323K 1591
2025
Q2
$323K Buy
2,001
+722
+56% +$115K 0.04% 626
2025
Q1
$218K Sell
1,279
-3,132
-71% -$544K 0.03% 816
2024
Q4
$733K Buy
4,411
+3,008
+214% +$514K 0.1% 229
2024
Q3
$241K Sell
1,403
-1,559
-53% -$258K ﹤0.01% 1972
2024
Q2
$456K Buy
2,962
+1,210
+69% +$182K 0.01% 1623
2024
Q1
$269K Sell
1,752
-1,328
-43% -$202K ﹤0.01% 2057
2023
Q4
$487K Buy
3,080
+1,658
+117% +$238K ﹤0.01% 1577
2023
Q3
$208K Buy
+1,422
New +$217K ﹤0.01% 2292
2021
Q4
Sell
-2,584
Closed -$429K 1699
2021
Q3
$429K Buy
+2,584
New +$441K 0.01% 822
2021
Q1
Sell
-1,477
Closed -$248K 1133
2020
Q4
$248K Buy
+1,477
New +$240K 0.01% 1194
2019
Q4
Sell
-6,087
Closed -$753K 2427
2019
Q3
$753K Buy
+6,087
New +$810K 0.01% 1006
2019
Q1
Sell
-7,155
Closed -$889K 1990
2018
Q4
$889K Buy
+7,155
New +$978K 0.01% 692
2017
Q2
Sell
-1,977
Closed -$208K 959
2017
Q1
$208K Buy
+1,977
New +$198K 0.04% 633

Other funds holding FBT

Two Sigma Securities's FBT Position: Q3 2025 in Review

Two Sigma Securities sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2025, closing a stake of 2,001 shares — an estimated $323K sold.

Two Sigma Securities first reported a position in FBT in Q1 2017 and held it in 13 quarters. The position peaked at $889K in Q4 2018. 253 funds tracked by Wall St. Rank hold FBT as of Q3 2025.

  • Two Sigma Securities reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 2,001 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2025, an estimated $323K.
  • Two Sigma Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2017 and held it in 13 quarters.
  • Two Sigma Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $889K in Q4 2018.
  • 253 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.